C83.32 Diffuse large B-cell lymphoma, intrathoracic lymph nodes

Name of the Condition

• Diffuse Large B-Cell Lymphoma, Intrathoracic Lymph Nodes (ICD-10 Code: C83.32)

Summary

Diffuse large B-cell lymphoma (DLBCL) is an aggressive type of non-Hodgkin lymphoma that originates in B-cells, a type of white blood cell. It is characterized by rapidly growing tumors in the lymph nodes or other lymphoid tissues. This code specifies involvement of the intrathoracic lymph nodes, which include those in the chest cavity. DLBCL is one of the most common subtypes of non-Hodgkin lymphoma and can occur in various parts of the body.

Causes

The exact cause of DLBCL is not fully understood. It is believed to result from genetic mutations in B-cells, which may be triggered by factors such as previous infections (e.g., Epstein-Barr virus), immune system dysfunctions, or exposure to certain environmental agents. These mutations disrupt normal cell growth and division, leading to uncontrolled proliferation.

Risk Factors

• Advanced age (most common in older adults)
• Weakened immune system (e.g., from HIV, organ transplants, or immunosuppressive drugs)
• Family history of lymphoma
• Exposure to certain chemicals or radiation
• Chronic infections (e.g., hepatitis C)

Symptoms

• Swollen, painless lymph nodes in the chest
• Unexplained weight loss
• Fever
• Night sweats
• Fatigue
• Loss of appetite
• Shortness of breath or chest pain
• Cough

Diagnosis

Diagnosis involves a combination of physical examination, imaging studies (e.g., CT scans or PET scans), and biopsy of the affected lymph nodes. A pathologist examines the tissue sample to confirm the presence of DLBCL and rule out other conditions. Additional tests, such as blood work or bone marrow biopsy, may be performed to assess the extent of the disease.

Treatment Options

Treatment typically includes chemotherapy, often combined with immunotherapy (e.g., rituximab). Radiation therapy may be used for localized disease. In some cases, stem cell transplantation or targeted therapies may be considered, depending on the patient's overall health and disease stage.

Prognosis and Follow-Up

Prognosis varies based on factors like age, overall health, and disease stage. Many patients respond well to treatment, but relapse can occur. Regular follow-up appointments, including imaging and blood tests, are essential to monitor for recurrence or complications.

Complications

• Tumor lysis syndrome (due to rapid cell death during treatment)
• Infection risk from weakened immune system
• Organ damage from tumor growth or treatment side effects
• Recurrence of lymphoma

Lifestyle & Prevention

• Maintain a healthy immune system through balanced nutrition and regular exercise.
• Avoid known environmental risk factors (e.g., excessive radiation or certain chemicals).
• Manage chronic infections promptly.
• Discuss vaccination schedules with a healthcare provider, especially if immunosuppressed.

When to Seek Professional Help

Seek immediate medical attention for persistent symptoms like unexplained weight loss, fever, night sweats, or chest pain. Early evaluation is critical for timely diagnosis and treatment.

Tips for Medical Coders

Use this code for diffuse large B-cell lymphoma specifically involving intrathoracic lymph nodes. Ensure documentation supports the anatomical location to justify code assignment. Verify that the diagnosis aligns with pathology reports and clinical findings.